Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H17NO |
| Molecular Weight | 203.2802 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N1CCCC1)C(=O)C2=CC=CC=C2
InChI
InChIKey=KPUJAQRFIJAORQ-UHFFFAOYSA-N
InChI=1S/C13H17NO/c1-11(14-9-5-6-10-14)13(15)12-7-3-2-4-8-12/h2-4,7-8,11H,5-6,9-10H2,1H3
| Molecular Formula | C13H17NO |
| Molecular Weight | 203.2802 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL224 Sources: https://www.ncbi.nlm.nih.gov/pubmed/30845376 |
5.6 null [pKi] | ||
Target ID: CHEMBL228 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27799294 |
188.0 µM [IC50] | ||
Target ID: CHEMBL222 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27799294 |
0.305 µM [IC50] | ||
Target ID: CHEMBL238 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27799294 |
0.54 µM [IC50] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:56:54 GMT 2025
by
admin
on
Mon Mar 31 21:56:54 GMT 2025
|
| Record UNII |
01DP8CH58H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-alpha-Pyrrolidinopropiophenone
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID50897462
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY | |||
|
01DP8CH58H
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY | |||
|
209045
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY | |||
|
.ALPHA.-PYRROLIDINOPROPIOPHENONE
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY | I tried it many times and i can say, that only IV method of using is good to understand the effects. Really. When you eat it or snort it, a-PPP is about nothing special. But 100-150 mg IV it's a proper way. Strong rush, stronger than meth or coke IV | ||
|
19134-50-0
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY | |||
|
ALPHA-PYRROLIDINOPROPIOPHENONE
Created by
admin on Mon Mar 31 21:56:54 GMT 2025 , Edited by admin on Mon Mar 31 21:56:54 GMT 2025
|
PRIMARY | α-Pyrrolidinopropiophenone (α-PPP),[1] is a stimulant drug. It is similar in structure to the appetite suppressant diethylpropion and has analogous effects in animals. Little is known about this compound, but it has been detected by laboratories in Germany as an ingredient in "ecstasy" tablets seized by law enforcement authorities. This drug has been found to produce stimulant effects in animals and presumably also produces these effects in humans, based on the context in which it has been found. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
|